MapLight Therapeutics, Inc.
MPLT
$13.63
$0.644.93%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -92.43M | -80.98M | -77.58M | -- | -- |
| Total Depreciation and Amortization | 683.00K | 720.00K | 701.00K | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 799.00K | 356.00K | 1.13M | -- | -- |
| Change in Net Operating Assets | -9.91M | -4.52M | -3.07M | -- | -- |
| Cash from Operations | -100.86M | -84.42M | -78.82M | -- | -- |
| Capital Expenditure | -546.00K | -768.00K | -770.00K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 96.51M | -42.52M | -80.02M | -- | -- |
| Cash from Investing | 95.97M | -43.29M | -80.79M | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 37.00K | 295.00K | 294.00K | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 0.00 | 0.00 | 119.96M | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -442.00K | -2.24M | -2.19M | -- | -- |
| Cash from Financing | -405.00K | -1.95M | 118.06M | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.30M | -129.66M | -41.54M | -- | -- |